← Evidence map

ArticleAllergy2025

Healthcare Resource Utilisation and Costs of Mepolizumab Initiation: A 5-Year National Cohort Analysis.

Arnaud Bourdin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39936563